I am glad to read CYL is moving Trident forward while also getting the 40+ yrs of drill data from numerous different operators in Marymia, plutonic, and bryah basin sorted out and modeled so that company can pursue the very best projects first. If I recall, hermes/hermes south got about 500kt at 1.4gpt ready to go with haul road already developed. Imo this is the lowest hanging fruit and we could fill 1st 1.8mmt mill for 12 months with 1.3mmt from plutonic underground+500mmt from hermes south. In Marymia K1 and K2 underground are already permitted. Open pits at phb1 that stretch between K2 and K1 already fully permitted in past by barrick. This is area vango hit bonanza 7m of 103gpt gold. Vango also permitted 2km pipeline to dewater K2 underground into K1 open pit. Imo K2 underground is less complicated than trident with its aquifer. K2 underground got nice little resource grading like 9gpt. With this project pipeline imo cyl need to start up 2d mill at 1.2mmt per year asap. Mill refurb gonna cost $25mm...
- Forums
- ASX - By Stock
- CYL
- Ann: Quarterly activities report
Ann: Quarterly activities report, page-18
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.85 |
Change
-0.240(7.77%) |
Mkt cap ! $641.7M |
Open | High | Low | Value | Volume |
$2.93 | $2.93 | $2.80 | $3.440M | 1.204M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 8896 | $2.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.85 | 4605 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 5482 | 2.840 |
14 | 30295 | 2.830 |
4 | 3811 | 2.820 |
4 | 9260 | 2.810 |
7 | 13061 | 2.800 |
Price($) | Vol. | No. |
---|---|---|
2.850 | 4920 | 5 |
2.860 | 61326 | 10 |
2.870 | 7440 | 4 |
2.880 | 13421 | 5 |
2.890 | 2150 | 1 |
Last trade - 14.43pm 12/11/2024 (20 minute delay) ? |
Featured News
CYL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online